These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2251777)

  • 21. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
    Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
    Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
    [No Abstract]   [Full Text] [Related]  

  • 22. New possibilities in the treatment of urinary tract infections.
    Leigh DA
    J Chemother; 1989 Jul; 1(4 Suppl):840-2. PubMed ID: 16312663
    [No Abstract]   [Full Text] [Related]  

  • 23. Metronidazole, clindamycin, and quinolones.
    Hammill HA
    Obstet Gynecol Clin North Am; 1989 Jun; 16(2):317-28. PubMed ID: 2674799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Maxaquin and ciprofloxacin in the treatment of complicated and recurrent urinary infections in adults].
    Savitskaia KI; Trapeznikova MF; Nekhorosheva AG; Solodilova OE; Nasonov VN; Dutov VV; Kalinin VN; Shanina AG; Rusanova EV
    Klin Med (Mosk); 1994; 72(2):38-42. PubMed ID: 8015241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experiences with a new chemotherapeutic agent for urinary infections].
    Bauer KM
    Chemotherapy; 1969; 14():Suppl:38-43. PubMed ID: 4908563
    [No Abstract]   [Full Text] [Related]  

  • 26. The treatment of urinary tract infections in children.
    Block CR
    J Okla State Med Assoc; 1971 Oct; 64(10):417-9. PubMed ID: 5110322
    [No Abstract]   [Full Text] [Related]  

  • 27. Uncomplicate the treatment of uncomplicated urinary tract infections.
    Ditmanson LF; Apgar DA
    Arch Intern Med; 1996 Jan; 156(1):111-3. PubMed ID: 8526690
    [No Abstract]   [Full Text] [Related]  

  • 28. [Tested and new chemotherapy in infectious diseases].
    Hoigné R; Keller MF
    Schweiz Med Wochenschr; 1972 Jul; 102(27):933-40. PubMed ID: 4558901
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost-effective management of complicated urinary tract infections.
    Cox CE
    Adv Ther; 1995; 12(4):222-35. PubMed ID: 10155350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Susceptibility in vitro to certain quinolines of gram-negative bacteria and gram-positive cocci causing urinary tract infections].
    Mróz E; Jankowski S; Bartelmus J; Grzybek-Hryncewicz K; Ruczkowska J; Starek J; Boratyńska M
    Med Dosw Mikrobiol; 1993; 45(1):115-8. PubMed ID: 8231429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficacy of ofloxacin, ciprofloxacin and NY-198 in experimentally infected normal and alloxan-induced diabetic mice.
    Obana Y; Nishino T
    Drugs Exp Clin Res; 1988; 14(5):327-31. PubMed ID: 3219995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro sensitivities of urinary tract pathogens to lomefloxacin and five other antimicrobial agents.
    Peddie BA
    N Z Med J; 1989 Jun; 102(869):298. PubMed ID: 2733911
    [No Abstract]   [Full Text] [Related]  

  • 33. Quinolones in urology.
    Nielsen KT; Madsen PO
    Urol Res; 1989; 17(2):117-24. PubMed ID: 2660393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of urinary tract infections, decubitus ulcer and pneumonia in the aging person.
    Ramírez-Ronda CH; Ballesté CR; Meléndez B; Vélez M; Fontán L; Saavedra S; González G
    Bol Asoc Med P R; 2003; 95(6):42-50. PubMed ID: 15449791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Should the use of gyrase inhibitors be limited to hospitals?].
    Shah PM
    Immun Infekt; 1990 Jun; 18(3):69-70. PubMed ID: 2165996
    [No Abstract]   [Full Text] [Related]  

  • 36. [New quinolones, new indications].
    Stahl JP
    Presse Med; 1993 Nov; 22(36):1807-9. PubMed ID: 8309907
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections.
    Mazzei T; Cassetta MI; Fallani S; Arrigucci S; Novelli A
    Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S35-41. PubMed ID: 16829051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity of urinary staphylococci to ciprofloxacin and acrosoxacin.
    Kent AF; Speller DC
    Eur J Clin Microbiol; 1985 Apr; 4(2):139-40. PubMed ID: 3159570
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluoroquinolones: how to use (but not overuse) these antibiotics.
    Sable CA; Scheld WM
    Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Erythrocytic glucose-6-phosphate dehydrogenase deficiency, hemolysis and diabetic ketoacidosis].
    Rodríguez Cuartero A
    An Med Interna; 1999 Oct; 16(10):542-3. PubMed ID: 10603677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.